← Eichor
Condition: Msk Conditions Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Msk Conditions

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Genicular Artery Embolization for Reducing Pain in Medically Refractory Symptomatic Knee Osteoarthritis
Phase 2 · 1 location(s) · University of Chicago · NCT06859164A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Phase 2 · 80 location(s) · Boehringer Ingelheim · NCT06962839Virtual Reality and Standard Care vs. Standard Care Alone for Acute MSK Pain in Geriatric ED Patients
NA · 1 location(s) · Antonios Likourezos · NCT06685107FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07638371A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Phase 2/Phase 3 · 91 location(s) · EyeBiotech Ltd. · NCT07440225A Study of NTRX-07 in Participants With Alzheimer's Disease
Phase 2 · 6 location(s) · NeuroTherapia, Inc. · NCT07058688Safety and Tolerability of EO2002
Phase 1 · 1 location(s) · Asociación para Evitar la Ceguera en México · NCT05587205Musculoskeletal and Pelvic Floor Health in Female Chronic Overlapping Pelvic Pain Conditions
Phase N/A · 1 location(s) · Loyola University · NCT05750212Precision Based Primary Care for Patients With Musculoskeletal Disorders
Phase N/A · 1 location(s) · Karolinska Institutet · NCT07603674Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Deg
Phase 3 · 79 location(s) · Adverum Biotechnologies, Inc. · NCT07482176Effect of Synbiotic Supplementation on the Prevention of Mucositis in Cancer Patients Undergoing Chemotherapy
NA · 1 location(s) · Federal University of Minas Gerais · NCT06576986Are We Providing Timely Access to Musculoskeletal Outpatient Therapy Services? an Exploratory Study
Phase N/A · 1 location(s) · Cardiff and Vale University Health Board · NCT06829875Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research
Phase 3 · 2 location(s) · Oculis · NCT07623668A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non
Phase 2 · 14 location(s) · Galimedix Therapeutics Inc · NCT06659549Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
Phase 3 · 181 location(s) · AbbVie · NCT05407636Sarcopenia in Colorectal Cancer Patients, Intervention Study
NA · 1 location(s) · Hospital Universitari de Bellvitge · NCT05491434Safety and Clinical Applicability of Transcorneal Electrical Stimulation (TES) in Geographic Atrophy
NA · 5 location(s) · Okuvision GmbH · NCT07531927Efficacy of Antibiotic Treatment for Patients With Chronic Low Back Pain and Modic Type I Changes - Randomized Placebo-c
Phase 3 · 1 location(s) · Bart Koes · NCT06771492A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Phase 2/Phase 3 · 63 location(s) · EyeBiotech Ltd. · NCT07496567Roxadustat for Bone and Neuropsychiatric Aspects in Hemodialysis Patients
Phase 1/Phase 2 · 1 location(s) · Mansoura University · NCT06917950Cryoneurolysis for Acute Postoperative Pain Following Total Knee Arthroplasty
NA · 1 location(s) · Copenhagen University Hospital, Hvidovre · NCT06088602Feasibility and Acceptability of an Evidence-Informed Virtual Intervention to Reduce Perceptions of Injustice Following
NA · 1 location(s) · McGill University · NCT07072702Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
Phase 3 · 17 location(s) · Laboratoires Thea · NCT06891443
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.